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ABSTRACT
The G12/13 class of heterotrimeric G proteins, comprising the
a-subunits Ga12 and Ga13, regulates multiple aspects of cellular
behavior, including proliferation and cytoskeletal rearrange-
ments. Although guanine nucleotide exchange factors for the
monomeric G protein Rho (RhoGEFs) are well characterized
as effectors of this G protein class, a variety of other downstream
targets has been reported. To identify Ga12 determinants that
mediate specific protein interactions, we used a structural and
evolutionary comparison between the G12/13, Gs, Gi, and Gq
classes to identify “class-distinctive” residues in Ga12 and
Ga13. Mutation of these residues in Ga12 to their deduced
ancestral forms revealed a subset necessary for activation
of serum response element (SRE)–mediated transcription,
a G12/13-stimulated pathway implicated in cell proliferative
signaling. Unexpectedly, this subset of Ga12 mutants showed
impaired binding to heat-shock protein 90 (Hsp90) while
retaining binding to RhoGEFs. Corresponding mutants of Ga13
exhibited robust SRE activation, suggesting a Ga12-specific
mechanism, and inhibition of Hsp90 by geldanamycin or small
interfering RNA–mediated lowering of Hsp90 levels resulted in
greater downregulation of Ga12 than Ga13 signaling in SRE
activation experiments. Furthermore, the Drosophila G12/13
homolog Concertina was unable to signal to SRE in mammalian
cells, and Ga12:Concertina chimeras revealed Ga12-specific
determinants of SRE activation within the switch regions and
a C-terminal region. These findings identify Ga12 determinants
of SRE activation, implicate Ga12:Hsp90 interaction in this
signaling mechanism, and illuminate structural features that
arose during evolution of Ga12 and Ga13 to allow bifurcated
mechanisms of signaling to a common cell proliferative
pathway.
Introduction
The ability to perceive and respond to information from
the environment is a fundamental property of living cells.
G protein–coupled receptors (GPCRs) are integral membrane
proteins that evolved to detect a wide range of extracellular
signals, including neurotransmitters, hormones, odorants,
and light. On activation, GPCRs undergo a conformational
change that stimulates heterotrimeric G proteins, intracellular
signaling molecules that consist of a GTP-binding a-subunit that
exists in 1:1:1 stoichiometry with a b- and a g-subunit. This
heterotrimer is inactive when Ga is GDP-bound and GPCR
activation causes Ga to exchange GDP for GTP, dissociate from
the Gbg heterodimer, and activate downstream effector proteins
(Oldham andHamm, 2008). Ga proteins are categorized into four
classes based on amino acid sequence: Gs, Gi, Gq, and G12/13.
Although each class signals to distinct effector proteins, Ga
proteins share a common fold; thus, it is widely accepted that Ga–
effector interactions are dictated by class-specific amino acids that
create permissive binding surfaces (Cabrera-Vera et al., 2003).
Understanding the principles that govern Ga–effector interaction
is essential to deciphering the role of specific signaling pathways.
The G12/13 class of Ga proteins is involved in signaling net-
works that regulate cell migration, cytoskeletal rearrangements,
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adhesion, apoptosis, and growth (Juneja and Casey, 2009;
Suzuki et al., 2009). Consistent with their role as signaling
hubs in these pathways, overexpressed or constitutively
activated Ga12 and Ga13 are potent stimulators of oncogenic
transformation (Chan et al., 1993; Jiang et al., 1993; Xu et al.,
1994). Some of these responses appear to involve transcrip-
tional activation of growth-promoting genes governed by
promoters harboring the serum response element (SRE)
(Vara Prasad et al., 1994; Hill et al., 1995; Fromm et al.,
1997). Other responses point to cell migration: endogenous
Ga12 levels correlate with the degree of metastatic invasive-
ness in breast cancer tissue samples (Kelly et al., 2006a), and
androgen-insensitive, invasive prostate tumor cells exhibit
higher Ga12 levels than less aggressive prostate cancers
(Kelly et al., 2006b). Despite 65% amino acid identity, Ga12
and Ga13 have nonoverlapping roles in signaling, embryonic
development, and disease physiology. Mice lacking Ga13
exhibit embryonic lethality with impairment in vascular
development (Offermanns et al., 1997), whereas mice lacking
Ga12 appear to develop normally (Gu et al., 2002). However, in
mice that are haplo-insufficient for Ga13, at least one wild-
type allele of Ga12 is required to avoid lethality (Worzfeld
et al., 2008), suggesting that Ga12 function during develop-
ment is not eclipsed by Ga13. Also, studies of mouse embryonic
fibroblasts lacking Ga12 and Ga13 reveal that both proteins
are necessary for orientation of the microtubule-organizing
center (Goulimari et al., 2008).
The mechanisms through which Ga12 and Ga13 stimulate
cell proliferation are not well understood. The best charac-
terized effector proteins are Rho-specific guanine nucleotide
exchange factors (RhoGEFs) that interact with Ga12 and Ga13
via RGS (regulator of G protein signaling) homology domains;
these include p115RhoGEF, leukemia-associated RhoGEF
(LARG), and PDZ-RhoGEF (Sternweis et al., 2007). In addition
to regulating cytoskeletal events such as contraction, this
G12/13-RhoGEF-Rho axis also stimulates transcription through
the SRE, a promoter element of the c-fos protooncogene (Fromm
et al., 1997; Bhattacharyya and Wedegaertner, 2000; Shi et al.,
2000). This signaling event is mediated by the transcriptional
activator serum response factor, which itself requires Rho-
mediated nuclear translocation of its cofactor, myocardin-related
transcription factor-A (MRTF-A) (Wang et al., 2002). Although
Ga12 andGa13 signal through several common binding partners,
numerous studies provide evidence of selectivity within the
G12/13 class (Kelly et al., 2007). For example, activity of heat-
shock protein 90 (Hsp90) is required for Ga12, but not Ga13, to
stimulate cellular transformation (Vaiskunaite et al., 2001).
Hsp90 is a molecular chaperone that forms a homodimer in
the cytoplasm, and hydrolysis of ATP at N-terminal binding
pockets within this dimer facilitates engagement and stabi-
lization of a wide variety of Hsp90 client proteins, many of
which are implicated in cancer progression (Samant et al.,
2012). Hsp90 binds specifically to Ga12 within the G12/13
class, but the structural features that mediate this interaction
are unknown.
Recent studies used a taxonomic comparison of Ga proteins
to identify changes in key residues that contributed to the
evolutionary diversification of the four classes (Friedman
et al., 2009; Temple et al., 2010). In the present study, we
mutated “class-distinctive” residues in Ga12 to ancestral
forms to dissect their roles in distinct signaling pathways. Our
results revealed a subset of these class-distinctive mutations
in Ga12 that disrupted both SRE activation and Hsp90
binding. Ga13 variants harboring identical mutations dis-
played robust SRE activation, suggesting a Ga12-specific
mechanism. In addition, the Drosophila G12/13 homolog
Concertina was unable to drive SRE signaling when expressed
in mammalian cells, and subsequently we used this protein as
a platform to identify key determinants of growth signaling
in the switch regions and C-terminal region of Ga12. These
findings define Ga12-specific structural determinants of SRE
activation and implicate Hsp90 binding as a requirement for
this Ga12-mediated pathway.
Materials and Methods
Materials and DNA Constructs. Glutathione-S-transferase
(GST) fusions of the N-terminal 252 amino acids of p115RhoGEF and
the region spanning Leu320 to Arg606 of LARG were provided by
Tohru Kozasa (University of Illinois, Chicago) and have been described
previously (Meigs et al., 2005). A GST fusion of the C-terminal 107
amino acids of Hsp90-a was provided by Tatyana Voyno-Yasenetskaya
(University of Illinois, Chicago), and enhanced green fluorescent
protein (EGFP)–fused MRTF-A was a gift from Christopher Mack
(University of North Carolina, Chapel Hill). All point mutants of Ga12,
Ga13, and Concertina were engineered by oligonucleotide-directed
mutagenesis using the QuikChange II system (Agilent Technologies,
Englewood, CO), with the following exception to the manufacturer’s
instructions. Each initial amplification reaction was divided into equal
halves, with each receiving one of two mutagenic oligonucleotides for
the first two polymerase chain reaction (PCR) cycles. These half-
reactions were then combined and subjected to 15 additional PCR
cycles. Concertina mutants in the internal ribosomal entry site (IRES)
vector pLL-5.5 (Uetrecht and Bear, 2009) were engineered by first
excising the Concertina cDNA from pLL-5.5 using ApaI and EcoRI,
subcloning into a truncated pGEX-2T vector (GE Healthcare, Little
Chalfont, Buckinghamshire, UK) at these sites and then using
QuikChange II reagents to introduce codon substitutions. Mutants
were subcloned into pLL-5.5 and then confirmed by sequencing. To
introduce myc-Ga12
QL to pLL-5.5, we excised the Concertina cDNA
from pLL-5.5 by digesting with ClaI, blunting 59-overhangs with
Klenow and digesting with EcoRI. Next, myc-Ga12
QL cDNAwas excised
from pcDNA3.1 (Life Technologies, Grand Island, NY), using EcoRI
and the blunt end-generating PmeI, and was ligated into pLL-5.5. All
DNA constructs expressed in Drosophila cell culture were subcloned
into a metallothionein promoter, pmtA vector backbone (Life Technol-
ogies), and a myc epitope tag was introduced N-terminally after the
initiator Met using KOD Xtreme Hot Start Polymerase (EMD
Millipore, Billerica, MA). All Ga12/Concertina and Ga13/Concertina
chimeras were engineered by a two-step PCR procedure, in which
desired regions of the mutationally activated Ga12 (Q229L), Ga13
(Q226L), and Concertina (Q303L) cDNAs were amplified so that each
initial product contained an additional nine base pairs that overlapped
with the product amplified from the other cDNA. This created junctions
in which 18 base pairs formed, allowing the initial PCR products (two
for chimeras 1, 2, 3, and 4, three for all other chimeras) to be combined
with end primers in a second round of PCR cycling to generate a full
chimeric product. For N-terminal tagging of chimeras 3, 4, 5, and 4-sub,
the coding sequence was amplified by PCR with the myc epitope tag
EQKLISEEDL encoded in the forward primer immediately down-
stream of the initiator methionine, and each product was subcloned
into pcDNA3.11 (Life Technologies). All constructs were verified by
sequencing.
Expression and Immobilization of GST Fusion Proteins.
The GST fusion constructs were transformed into BL21(Gold)-DE3
cells (Agilent Technologies), liquid cultures were grown at 37°C under
75 mg/ml ampicillin selection to OD600 of 0.5–0.7, and recombinant protein
expression was induced by 0.5 mM isopropyl-b-D-thiogalactopyranoside
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(Fisher Scientific, Pittsburgh, PA). After 3 hours, the cells were lysed
on ice using 0.32 mg/ml lysozyme (MP Biomedicals, Santa Ana, CA),
and GST fusion proteins were bound to glutathione Sepharose 4B (GE
Healthcare) as described previously (Meigs et al., 2005). After three
washes in 50 mM Tris pH 7.7 supplemented with 1 mM EDTA, 1 mM
dithiothreitol, and 150 mM NaCl, samples were snap-frozen and
stored at 280°C.
Preparation of Detergent-Soluble Extracts Harboring Ga
Mutants. Human embryonic kidney cells (HEK293) were grown in
Dulbecco’s modified Eagle’s medium (Mediatech, Manassas, VA)
supplemented with 10% fetal bovine serum (Hyclone, Logan, UT),
penicillin, and streptomycin. For myc-Ga12
QL and each of the class-
distinctive mutants, 7.0 mg of plasmid DNA was transfected into a
10-cm dish of HEK293 cells at approximate 90% confluence, using
Lipofectamine 2000 (Invitrogen) in accordance with themanufacturer’s
instructions. After 36–40 hours, cells were scraped fromdishes, washed
twice with phosphate-buffered saline (PBS), and solubilized in lysis
buffer [50 mM HEPES pH 7.5, 1 mM EDTA, 3 mM dithiothreitol,
10 mM MgSO4, 1% (w/v) polyoxyethylene-10-lauryl ether] containing
the protease inhibitors 4-(2-aminoethyl)benzenesulfonyl fluoride hy-
drochloride (1.67 mM), leupeptin (2.1 mM), pepstatin (1.45 mM),
Na-tosyl-L-lysine chloromethyl ketone (58 mM), tosyl-L-phenylalanyl-
chloromethane (61 mM), and phenylmethylsulfonyl fluoride (267 mM).
Samples were centrifuged at 80,000g for 1 hour, and supernatants
were snap-frozen and stored at 280°C.
Trypsin Protection Assays. HEK293 cells grown in 10-cm
dishes were transfected with various Ga12 constructs using Lipofect-
amine 2000, and tryptic digestions were performed as a modification
of the procedure of Kozasa and Gilman (1995). Briefly, cells were lysed
in 50 mM HEPES, pH 7.5, 1 mM EDTA, 3 mM dithiothreitol, and 1%
polyoxyethylene-10-lauryl ether containing the same protease inhib-
itors as lysis buffer (see preceding) but at 2-fold lower concentration.
Samples were cleared by centrifugation at 80,000g for 1 hour, and
supernatants were diluted 20-fold in volume using 50 mMHEPES pH
7.5, 1 mM EDTA, 3 mM dithiothreitol, and 10 mM MgSO4. Samples
were digested with 10 mg/ml TPCK-treated trypsin (New England
Biolabs, Ipswich, MA) for 20 minutes at 30°C, and proteolysis was
terminated by addition of 100 mg/ml lima bean trypsin inhibitor
(Worthington, Lakewood, NJ). Proteins were precipitated by addition
of 20% trichloroacetic acid and 0.8 mg/ml sodium deoxycholate,
washed with acetone, dried, and then analyzed by SDS-PAGE and
immunoblotting using J169 antisera specific to the Ga12 C terminus
(Kozasa and Gilman, 1995), provided by Tohru Kozasa (University of
Illinois, Chicago).
Protein Interaction Assays. Extracts from transfected HEK293
cells were diluted in lysis buffer (see preceding description) lacking
polyoxyethylene-10-lauryl ether, using sufficient volume to dilute this
detergent to 0.05% (w/v). Next, Sepharose-bound GST fusion proteins
were added and continuously inverted for 2 hours at 4°C. A per-
centage of the diluted extract was set aside as starting material
(i.e., load) before Sepharose addition. Samples were centrifuged at
1,300g, and pellets were washed extensively and subjected to SDS-
PAGE and immunoblot analysis using an antibody specific to either
the Ga12 N terminus (Santa Cruz Biotechnology, Santa Cruz, CA),
Ga13 (EMD Millipore), or the myc epitope tag (EMD Millipore),
followed by alkaline phosphatase conjugated secondary antibodies
(Promega, Madison, WI). For each Ga protein, the Gaussian intensity
value was determined for the ∼44-kDa band in the precipitated
material and divided by the Gaussian intensity of the corresponding
∼44 kDa-band in the load to normalize Ga variants for different
expression levels in cells.
RhoA Activity Assays. Pull-downs using the Rho-binding do-
main (RBD) of Rhotekin were performed as previously described (Ren
et al., 1999) with the following minor modifications. Cells were
washed with ice-cold Tris buffered saline (pH 7.6) with 2 mM MgCl2
and lysed in buffer A (50 mM Tris pH 7.6, 500 mM NaCl, 1% Triton
X-100, 0.1% SDS, 0.5% sodium deoxycholate, 0.5 mM MgCl2, 200
mM orthovanadate, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM
phenylmethylsulfonyl fluoride). Lysates were sonicated briefly,
clarified by centrifugation, and equalized for total volume, as well as
protein concentration, and then incubated with 30 mg of GST-RBD
beads prepared as previously described (Guilluy et al., 2011). Samples
were washed with buffer B (50 mM Tris pH 7.6, 150 mM NaCl, 1%
Triton X-100, 0.5 mM MgCl2, 200 mM orthovanadate, and protease
inhibitors as described) three times before SDS-PAGE. Active RhoA,
total RhoA, Ga12, and actin levels were determined by immunoblotting
with anti-RhoA (polyclonal antibody 67B9; Cell Signaling Technology,
Danvers, MA), anti-Ga12 (Santa Cruz Biotechnology), and anti-actin
(clone C4; EMD Millipore). Total RhoA and Ga12 levels were similarly
determined using an aliquot of whole cell lysate.
Reporter Gene Assays and RNA Interference. SRE-luciferase
plasmid was provided by Channing Der (University of North
Carolina, Chapel Hill). HEK293 cells grown to approximately 80%
confluence in 12-well plates were transfected with 0.2 mg of SRE-
luciferase and 0.02 mg pRL-TK harboring the cDNA for Renilla
luciferase (Promega), plus 1.0 mg plasmid encoding a variant of myc-
Ga12
QL, Ga13
QL, or Concertina. Plasmidmixtures were combined with
Lipofectamine 2000 in Opti-MEM reduced serum medium (Life
Technologies) according to the manufacturer’s instructions. For
RNA interference experiments, small interfering RNA (siRNA)
specific to Hsp90-a (ON-TARGETplus SMARTpool; Thermo Scientific
Dharmacon, Pittsburgh, PA) was reconstituted in 1 siRNA buffer
(Thermo Scientific Dharmacon), and 60 pmol per sample was
combined with the plasmids described above and cotransfected using
Lipofectamine 2000 into 12-well plates of HEK293 cells. Assays for
SRE activation were performed as described previously (Meigs et al.,
2005). Briefly, cells were washed with phosphate-buffered saline and
lysed in 1 passive lysis buffer (Promega), and lysates were analyzed
using a Dual-luciferase assay system and GloMax 20/20 luminometer
(Promega). Light output from firefly luciferase activity was divided by
output from Renilla luciferase activity to normalize for variations in
transfection efficiency.
Visualization of MRTF-A Localization. Subcellular distribu-
tion of EGFP-tagged MRTF-A was assayed as previously reported
(Hinson et al., 2007; Medlin et al., 2010) with minor modifications.
HEK293 cells grown on glass coverslips to approximately 50%
confluence were transfected with plasmids encoding EGFP-MRTF-A
and variants of Ga12 using Lipofectamine 2000 (Life Technologies).
After 36 hours, cells were washed in PBS and fixed in 4%
paraformaldehyde for 10 minutes, rinsed three times in PBS, and
mounted on 49,6-diamidino-2-phenylindole–Fluoromount-G (Southern
Biotech, Birmingham, AL). Cells were visualized on a TE-2000S
(Nikon, Melville, NY) equipped with a SPOT monochrome digital
camera (Diagnostic Instruments, Sterling Heights, MI). Individual
cells were examined for 49,6-diamidino-2-phenylindole fluorescence to
define the nuclear compartment, followed by green fluorescence to
visualize EGFP-MRTF-A distribution.
Drosophila Cell Culture and Imaging. S2 cells were obtained
and cultured as previously described (Rogers and Rogers, 2008). Cells
were maintained in SF900 media (Life Technologies) and were
transfected with 2 mg/ml DNA using the Amaxa nucleofector system
(Lonza, Basel, Switzerland) with KitV and program G-30. Cells were
plated onto ConA-coated coverslips in petri dishes and induced with
1 mM CuSO4 for 2.5 hours. Cells were prepared for imaging as
previously described (Rogers and Rogers, 2008). Probes used were
1:400 diluted anti-myc (9E10) antibody (DSHB, Iowa City, IA) and
1:100 diluted Alexa Fluor 488 phalloidin (Life Technologies). Cells
were imaged using an Eclipse Ti-E (Nikon).
Data Analysis and Statistics. Immunoblot results were quanti-
fied using a Kodak Gel Logic 100 imaging system equipped with
Molecular Imaging 5.X software (Carestream Health, New Haven,
CT) to calculate Gaussian fit for each protein band. For graphical data
presentation, error bars represent either 6 range or 6 S.E.M., as
indicated in the figure legends (Figs. 1–7). Student’s t test with
unequal variance was used to compare the means of two data sets
with one measurement variable, and the Kruskal–Wallis test was
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used for one-way analysis of variance. A P value , 0.05 was
considered significant.
Results
Identification and Mutation of Class-Distinctive
Residues within Ga12. Each Ga class is thought to signal
to its downstream effectors via specialized contact surfaces
that are ultimately determined by primary sequence. There-
fore, we hypothesized that these effector-binding surfaces
harbor unique, “class-distinctive” amino acids that confer
specificity for downstream signaling partners. To identify
G12/13 class-distinctive residues, we conducted a structural
alignment of all four classes of mammalian G protein a-sub-
units: Gs, Gi, Gq, and G12/13 as described by Temple et al.
(2010) and identified 19 class-distinctive residues in the G12/13
class. Of these residues, 16 were located either in Ga12 alone
or in both Ga12 and Ga13 and were selected for further study.
Through ancestral reconstruction analyses, we determined that
the “nonclass-distinctive” counterpart, represented by a residue
invariant among the other three mammalian Ga classes, most
frequently represents the ancestral amino acid value (Temple
et al., 2010). We engineered substitutions within a myc-tagged,
constitutively active variant (Q229L) of Ga12, termed myc-
Ga12
QL, with each mutation converting a class-distinctive
residue to its nonclass-distinctive form (Fig. 1A). Each mutant
was engineered as a single substitution, with the exception
of Q232E/Q234K in which two Gln residues were changed in
the same construct, yielding a total of 15 Ga12 variants. When
expressed in HEK293 cells, nearly all class-distinctive mutants
were detected at levels comparable to unaltered myc-Ga12
QL
(Fig. 1B). Endogenous Ga12 migrated slightly faster on gels
than the myc-tagged variants and was not detectable (Fig. 1B,
vector) except when immunoblots were developed for relatively
long times.
Class-Distinctive Ga12 Mutants Selectively Uncoupled
from SRE Activation and Hsp90 Binding. We examined
the Ga12 class-distinctive mutants for activation of SRE-
mediated transcription, a Rho-dependent cell growth pathway
that is responsive to Ga12 and Ga13 (Fromm et al., 1997;
Bhattacharyya and Wedegaertner, 2000). As shown in Fig. 2A,
most of these mutants displayed normal or moderately impaired
ability to stimulate a SRE-luciferase reporter construct (.50%
of control, nonmutated myc-Ga12
QL); however, the mutant
L201R and the double-mutant Q232E/Q234K showed severe
impairment of SRE stimulation (,20% of control), whereas the
mutant F237I showed near-complete loss of SRE activation
that was comparable to a constitutively inactive mutant
(G228A) of Ga12 that is unable to release GDP (Miller et al.,
1988). We further tested these SRE-uncoupled Ga12 mutants
for an additional readout in this signaling pathway, nuclear
translocation of MRTF-A/megakaryoblastic leukemia 1. This
trafficking is mediated by activated Ga12 and Ga13 and
requires downstream Rho activation, which participates in
mediating MRTF-A nuclear import and activity by decreasing
the availability of the MRTF-A binding partner, G-actin
(Evelyn et al., 2007; Medjkane et al., 2009). As shown in Fig.
2B, cells expressing EGFP-tagged MRTF-A and cotransfected
with myc-Ga12
QL showed a higher percentage of cells with
exclusively nuclear EGFP-MRTF-A staining than cells cotrans-
fected with the inactive (G228A) myc-Ga12. Although the SRE-
uncoupled mutants of myc-Ga12
QL (L201R, Q232E/Q234K,
F237I) showed varied results in this assay, all exhibited a lower
percentage of cells with nuclear EGFP-MRTF-A localization
than the positive control myc-Ga12
QL, suggesting the impaired
ability of these mutants to signal to SRE involves a mechanism
upstream of MRTF-A transport to the nucleus.
In parallel to the SRE activation studies shown in Fig. 2A,
we examined whether mutation of class-distinctive residues
in Ga12 to their nonclass-distinctive forms disrupted in-
teraction with specific effector proteins. Myc-tagged Ga12
QL
and its mutants were expressed in HEK293 cells and tested
for the ability to bind GST fusions of p115RhoGEF, LARG,
and Hsp90 (Fig. 3A). As shown in Fig. 3B, each of these
proteins was able to precipitate myc-Ga12
QL from cell extracts.
Fig. 1. Construction, expression, and solubilization of class-distinctive
Ga12 mutants. (A) Amino acid sequence of Ga12 is shown. Each class-
distinctive residue, indicated by an oval, was mutated to its nonclass-
distinctive form (above right of ovals) in myc-tagged, constitutively active
Ga12. Shaded areas indicate the switch I, II, and III regions, and the
dashed box indicates the site of the activating Q229L mutation. (B) The
indicated mutant constructs were expressed in HEK293 cells, from which
detergent-soluble extracts were subjected to immunoblot analysis as
described in Materials and Methods. All mutants were single amino acid
substitutions except the double-mutant Q232E/Q234K (QE/QK). Extracts
from cells transfected with the Q229L variant of myc-tagged Ga12 (12QL)
and empty pcDNA3.1 (vector) were analyzed in parallel.
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Among the class-distinctive mutants, L201R, F237I, and
Q232E/Q234K were most severely impaired in binding Hsp90,
with a precipitate-to-load ratio between 0 and 20% of the value
for myc-Ga12
QL (Fig. 3C; Table 1). This indicated that the subset
of Ga12 class-distinctive residues most indispensable for
stimulating SRE-mediated transcription were also the most
important in Ga12–Hsp90 interaction. These mutations that
attenuated SRE signaling and Hsp90 binding did not globally
affect Ga12 interaction with downstream targets, as all three
mutants bound strongly to LARG and p115RhoGEF (Fig. 3D;
Table 1). Furthermore, these mutations did not disrupt Ga12
structural conformation. As shown in Fig. 3E, the mutants
L201R, F237I, and Q232E/Q234K yielded a trypsin-protected
40-kDa fragment comparable to the fragment generated from
nonmutatedmyc-Ga12
QL, whereas the inactive G228A variant of
myc-Ga12 was fully digested. Therefore, it appears these Ga12
mutants retain fundamental properties of guanine nucleotide
binding, and their impairment in SRE stimulation and Hsp90
binding appears not to be caused by failed conformational
activation or other, nonspecific disruptions of protein folding or
effector binding.
Phylogenetic Substitutions of Class-Distinctive Ga12
Residues Have Differential Effects on SRE Signaling.
In addition to comparing the different mammalian Ga classes
to identify residues that confer signaling specificity, we
determined the phylogenetic timeline of G12/13 class-
distinctive residues by comparing divergent sequences from
sea sponge, roundworm, fruit fly, sea urchin, and mouse or
human (Temple et al., 2010). Evolutionary emergence of the
Fig. 2. Identification of class-distinctive mutants of Ga12 impaired in
SRE-mediated transcriptional activation. (A) HEK293 cells were trans-
fected with the plasmids SRE-luciferase (0.2 mg) and pRL-TK (0.02 mg)
plus 1 mg of plasmid encoding each indicated class-distinctive mutant of
myc-Ga12
QL (x-axis). Firefly luciferase activity values were normalized
for Renilla luciferase activity values and presented as a percent of positive
control myc-Ga12
QL (12QL) within the same experiment. Empty
pcDNA3.1 (vector) and Ga12 harboring the inactivating G228A mutation
(12GA) were examined as negative controls. Data presented are themean6
range of two independent experiments per myc-Ga12
QL variant, with
three or more experiments performed for mutants that showed greater
than 50% impairment of SRE stimulation. (B) HEK293 cells grown in six-
well plates were cotransfected with 1.0 mg of EGFP-MRTF-A plasmid and
1.0 mg of each indicated Ga12 construct. Cells (50 per transfection) were
scored for either diffuse or exclusively nuclear localization of the EGFP
signal, using 49,6-diamidino-2-phenylindole (DAPI) costaining to define
the boundaries of the nucleus. Examples are shown in the left panels (two
cells exhibiting diffuse EGFP-MRTF-A staining) and right panels (single
cell exhibiting nuclear staining of EGFP-MRTF-A). Scale bar is 10 mm.
The column graph shows results compiled from three independent trials,
presented as mean 6 S.E.M. Significance of the difference in mutant
values comparedwith positive control (12QL) was determined by Student’s t
test (*P , 0.05).
Fig. 3. Effector binding and conformational activation of SRE-uncoupled
class-distinctive Ga12 mutants. (A) GST fusions of the N-terminal 252
amino acids of p115RhoGEF (p115), the C-terminal 107 residues of
cytoplasmic Hsp90, and the region spanning Leu320 to Arg606 of LARG
were analyzed by SDS-PAGE and Coomassie blue staining. Unmodified
GST was analyzed in parallel. (B) Coprecipitation experiments using
these GST fusion proteins were performed on detergent extracts from
HEK293 cells expressing myc-tagged, constitutively active Ga12 (12QL) or
empty pcDNA3.1 (vect). (C) Coprecipitations of indicated Ga12 mutants by
immobilized Hsp90 are shown. For each panel, the left and center lanes
harbor samples in which Sepharose-bound GST-Hsp90 or GST (indicated
at top) were used to precipitate fractions from HEK293 extracts harboring
myc-Ga12
QL (12QL) or the mutants indicated at left. The right lane of
each panel (load) harbors 5% of the HEK293 extract set aside before
coprecipitation, and band intensities at ∼44 kDa were quantified and used
to normalize the coprecipitated bands for Ga12 variants indicated here, as
well as others (Table 1). A representative of three independent experi-
ments is shown. (D) Coprecipitation of myc-Ga12
QL and its indicated
mutants by multiple effectors are shown. The indicated GST fusions of
LARG and Hsp90, plus GST with no adduct (GST) are indicated, along
with the load for each sample. Data shown are a representative of three
independent experiments. (E) Trypsin protection assays were performed
on the indicated class-distinctive mutants, plus constitutively activated
(12QL) and inactivated (12GA) myc-Ga12. HEK293 cells grown in 10-cm
plates were transfected with 10 mg of plasmid DNA, and after 40 hours,
cell lysates were subjected to tryptic proteolysis as described in Materials
and Methods. Molecular weights are indicated at left in kilodaltons.
Results shown are one representative of three independent experiments.
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Leu residue immediately upstream of the switch I region
(Leu201 in Ga12; Leu198 in Ga13) was relatively recent for the
G12/13 class because a His residue occupies this position in
the sea urchin and Drosophila homologs, and the Caenorhab-
ditis elegans and sea sponge G12/13 proteins harbor other
residues (Fig. 4A). In contrast, Phe237 in the switch II region
of Ga12 is highly conserved in G12/13 proteins of all the taxa
examined (Fig. 4A) except Drosophila, in which Thr occupies
this position. To assess the structural and functional con-
sequences of these evolutionary changes within the G12/13
class, we mutated Leu201 and Phe237 in myc-Ga12
QL to the
corresponding Drosophila residues His and Thr, respectively.
The L201H mutant (i.e., mammal → fly) exhibited normal
SRE activation and binding to Hsp90, in sharp contrast to
L201R (i.e., class-distinctive → nonclass-distinctive) that
caused impairment of both functions (Fig. 4, B and C).
Surprisingly, the F237T mutant (mammal → fly) in myc-
Ga12
QL showed near-complete loss of SRE stimulation (Fig.
4B), phenocopying the Phe237 mutation to Ile (class-
distinctive → nonclass-distinctive), and both F237I and
F237T mutants were markedly impaired in Hsp90 binding
(Fig. 4C). For all variants of residues Leu201 and Phe237 that
we engineered, binding of Ga12 to LARG was unperturbed or
slightly diminished (Fig. 4C). In some experiments, protein
levels of mutants L201R and F237I were lower than the
positive control myc-Ga12
QL; therefore, to ascertain that
impaired SRE signaling was not due merely to lowered
expression of these mutants, we examined a series of cell
samples transfected with decreasing amounts of myc-Ga12
QL
plasmid (Fig. 4B). Mutants F237I and L201R showed
impaired SRE activation compared with myc-Ga12
QL
expressed at similar levels. From these data, we conclude
that Leu201 and Phe237 in mammalian Ga12 were critical
components of its evolved ability to stimulate SRE and bind
Hsp90, but the corresponding residues in the Drosophila G12/
13 homolog Concertina represent different stages of this
process. The His residue upstream of the switch I region in
Concertina is effectively a G12/13 class-distinctive residue
(i.e., facilitated the same signaling properties as Leu201 in
Ga12) and therefore might be an intermediate to fixation of
the Leu residue in mammalian G12/13 proteins. On the other
hand, the Thr residue in the switch II region of Concertina
fails to act as a G12/13 class-distinctive residue; its in-
troduction to Ga12 disrupted both SRE-mediated signaling
and Hsp90 binding. It remains to be determined whether this
Thr residue confers a unique signaling property in Concertina
TABLE 1
Coprecipitation of Ga12 class-distinctive mutants by downstream
effectors
For each class-distinctive mutant of myc-Ga12
QL (left column), precipitation by each
GST-fused effector protein (top row) and starting material (i.e., load) were quantified
as described in Materials and Methods to determine a precipitate:load ratio.
Categories are as follows: ++++, ratio .70% of positive control myc-Ga12
QL; +++,
40–70% of control; ++, 20–40% of control; +, 0–20% of control; 2, no detectable
coprecipitation. Each sample is the result of two trials, except for samples scoring ++,
+, or –, which were analyzed in at least three trials.
p115 LARG Hsp90
A30E ++++ ++++ ++/+++
A43K +++ +++ +++
E82G ++++ ++++ ++++
A87E ++++ ++++ ++++
R110M ++++ ++++ ++
A164C ++/+++ +++ ++++
L201R ++++ +++ 2/+
K204V +++ +++ ++/+++
K207T ++++ ++++ ++
QE/QK +++ ++++ 2/+
F237I ++/++++a ++++ +
I243V ++/+++ +++ ++++
S251A ++ ++++ +++
V325A +++ +++/++++ +++
T350C ++ ++ ++
aVariation spanning more than two categories.
Fig. 4. Ancestral and Concertina-specific substitutions of Ga12 residues
involved in SRE activation and Hsp90 binding. (A) An evolutionary profile
of selected class-distinctive G12/13 residues is shown, with position in the
primary amino acid sequence shown in superscript for Ga12 and Ga13
(Temple et al., 2010). (B) The indicated substitutions in myc-Ga12
QL (x-
axis) were examined for SRE-luciferase activation as described in
Materials and Methods, and results are presented as a percent of positive
control myc-Ga12
QL (12QL). Panels beneath this graph show expression
levels of the indicated mutants, matched with one of several different
samples of myc-Ga12
QL, as determined by immunoblot analysis of
HEK293 cell lysates using anti-Ga12 antibody. (C) Effects of the indicated
substitutions within Ga12 on coprecipitation by immobilized LARG and
Hsp90 are shown, with lysates from cells transfected with myc-Ga12
QL and
empty vector analyzed in parallel. Panel at left shows blot images
representative of three independent experiments, and panel at right
shows precipitate-to-load ratios as a percent of the same ratio determined
for myc-Ga12
QL (set at 100%). Quantitative data are presented as mean 6
S.E.M.
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despite the conservation of Phe at this position in the G12/13
class from sea sponge to humans. To our knowledge, these
results provide the first instance of a signaling function being
disrupted in a mammalian G12/13 protein by substitution of
corresponding sequence from an evolutionary homolog in the
same class.
Structural Determinants of Hsp90 Interaction Are
Selectively Required for Ga12 in G12/13-Mediated SRE
Activation. Ga13, like Ga12, is a potent stimulator of SRE-
mediated transcriptional activation (Fromm et al., 1997), and
activated mutants of both Ga12 and Ga13 are blocked in SRE
activation by the Clostridium botulinum C3 exoenzyme,
a specific inhibitor of Rho activity (Shi et al., 2000). To assess
the requirement for Hsp90 function in Ga12 and Ga13
signaling, we used a constitutively active (Q226L) variant of
Ga13 along with constitutively active Ga12 and examined
effects of the Hsp90 inhibitor geldanamycin on SRE activa-
tion. Hydrolysis of ATP is critical for Hsp90 in forming
a “clamped” complex with client proteins, and geldanamycin
disrupts this biologic function of Hsp90 by competing for ATP
binding to the N-terminal domain (Peterson and Blagg, 2009).
We found geldanamycin to partially block Ga12-mediated
activation of SRE-luciferase in HEK293 cells, whereas this
compound showed significantly lower efficacy in blocking
Ga13 stimulation of this reporter (Fig. 5A). This selectivity
of geldanamycin on Ga12 signaling within the G12/13
class agreed with previous findings in NIH3T3 fibroblasts
(Vaiskunaite et al., 2001). In addition, we tested the ability of
Ga12 and Ga13 to stimulate SRE-luciferase in HEK293 cells
cotransfected with siRNA targeting human Hsp90-a. These
experiments yielded results similar to the effects of geldana-
mycin; this RNA interference caused significantly greater
downregulation of Ga12-mediated SRE activation in compar-
ison with the Ga13-driven response (Fig. 5A). To determine
whether the SRE-uncoupled mutants define a mechanism
specific to Ga12 within the G12/13 family, we engineered
constitutively active Ga13 to harbor substitutions of Leu198
and Phe234 to their nonclass-distinctive forms (mutants
L198R and F234I) and their Concertina-specific forms
(mutants L198H and F234T). In striking contrast to Ga12,
these substitutions in Ga13 caused no disruption in SRE
signaling (Fig. 5B). We also examined the role of Ga13
residues that correspond to the class-distinctive Gln232/
Gln234 pair found in Ga12. As described already herein
(Figs. 2 and 3), the Q232E/Q234K mutant converts Gln
residues within the Ga12 switch II region to their nonclass-
distinctive forms, disrupting SRE stimulation and Hsp90
binding. Paradoxically, these nonclass-distinctive Glu and
Lys residues are present in Ga13, despite conservation of the
Gln/Gln pair in the G12/13 class for all nonmammalian taxa
examined (Fig. 4A). We hypothesized that “reversion” from
Gln/Gln to the ancestral Glu/Lys was necessary for Ga13 to
evolve its distinct mechanism of growth signaling, and
therefore we mutated Glu229 and Lys231 in Ga13 to a pair
of Gln residues and tested this E229Q/K231Qmutant in SRE-
luciferase assays. Surprisingly, these substitutions caused no
disruption of SRE activation triggered by constitutively active
Ga13 (Fig. 5B), suggesting that Glu229 and Lys231 of Ga13 are
uninvolved in its stimulation of SRE-mediated transcription,
whereas Gln residues at these positions in Ga12 are critical for
its mechanism of activating the same response. A structural
comparison of Ga12 to Ga13 in the switch II region reveals
similarities and differences in backbone and side-chain atoms
at the Q232E/Q234K positions (Fig. 5C). In Ga12, the Q232E
substitution alters only the charge of the side-chain, whereas
the Q234K substitution changes both size and charge. Taken
as a whole, these findings suggest that the effector proteins
stimulated by Ga12 and Ga13 in the pathway(s) leading to
SRE-mediated transcription are not identical and that in-
teraction with functional Hsp90 is a specific requirement of
Ga12 in this signaling response.
Class-Distinctive Mutants of Ga12 Uncouple SRE
Activation from Rho-Mediated Signaling. Our results,
shown in Fig. 4, revealed a single amino acid substitution
(F237T; mammal → fly) that uncoupled Ga12 from SRE
activation, and this finding compelled us to examine whether
the Drosophila Ga12 homolog Concertina could stimulate the
SRE pathway when expressed in mammalian cells. Concertina
is required for cell shape changes and migration during
gastrulation (Parks and Wieschaus, 1991), but its growth
signaling properties are not known. Because Concertina-specific
antibodies were not available, we subcloned both wild-type and
constitutively activeConcertina (bothQ303LandR277Cvariants)
into the mammalian cell expression vector pLL5.5 (Uetrecht and
Bear, 2009) harboring an IRES to allow translation from a
bicistronic mRNA, along with green fluorescent protein
(GFP). Neither wild-type nor constitutively active Concertina
(Q303L or R277C) stimulated SRE-luciferase when expressed
ectopically in HEK293 cells, despite the expression of GFP
(Fig. 6A). We were not able to obtain a definitive result in
experiments testing ability of the Q303L variant of Concer-
tina to trigger a cytoskeletal response in HEK293 cells (data
not shown); however, this Q303L variant was functional in its
normal cellular context as an activator of contractility in S2
cells (Fig. 6, B and C), as was the R277C variant (data not
shown). As a result of the acute disruption of Ga12-mediated
SRE signaling observed when Phe237 was converted to the
Concertina-specific Thr, we engineered the converse mutant
by replacing Thr311 of Concertina with the Ga12-specific Phe
residue. However, this T311F substitution did not confer on
Concertina the ability to activate SRE-mediated transcription
in HEK293 cells (Fig. 6A).
Of the class-distinctive Ga12 residues we identified as
critical for SRE activation, only the switch II region Gln/Gln
pair is conserved between Ga12 and Concertina. To determine
whether these Gln residues are important in Concertina-
driven cytoskeletal rearrangements, which is a signaling
pathway known to use the RhoGEF-Rho axis (Barrett et al.,
1997), we tested a Q306E/Q308K mutant of constitutively
active Concertina (Q303L) for the ability to stimulate S2
cell contraction. This Concertina mutant showed no loss of
efficacy in triggering contractility of S2 cells (Fig. 6, B and C),
suggesting that these Gln residues are not involved in the Ga-
driven mechanism that mediates these Rho-dependent cyto-
skeletal changes.We also directly examined the SRE-uncoupled
Ga12 mutants (L201R, F237I, and Q232E/Q234K) for Rho
activation, by using RBD assays to selectively precipitate GTP-
bound RhoA fromHEK293 cell lysates. As shown in Fig. 6D, the
F237I and L201Rmutants showed activation of Rho comparable
to positive control myc-Ga12
QL. The Q232E/Q234K mutant of
myc-Ga12
QL triggered a low, although significant, activation of
Rho in comparison with inactive, GDP-bound myc-Ga12, despite
the robust cytoskeletal response triggered in S2 cells by Con-
certina harboring the same substitutions.
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Ga12 Switch Regions and C Terminus Harbor In-
dependent Determinants of SRE Activation. Because
Concertina failed to stimulate SRE-mediated transcription in
HEK293 cells, we used this Drosophila Ga12 homolog as
a “blank canvas” in these mammalian cells for identifying
regions of Ga12 that mediate SRE activation. We engineered
a set of Ga12/Concertina chimeras, designated numbers 1–6, in
which a domain encompassing the three switch regions and the
flanking N- and C-terminal domains were interchanged in all
possible combinations (Fig. 7A). Each chimera was engineered
to harbor an activating Gln-to-Leu mutation within the switch
II region and was subcloned into the IRES vector pLL-5.5 to
allow normalization of expression through GFP immunoblot-
ting (Uetrecht and Bear, 2009). Strikingly, the only construct
that stimulated SRE signaling was chimera 4, which harbors
the N-terminal 275 residues of Concertina and an additional
178 residues comprising the switch regions and C terminus of
Ga12 (Fig. 7B). Whereas this chimera showed robust SRE
activation equal to or greater than myc-Ga12
QL, the other
chimeras exhibited no SRE stimulation, with readings compa-
rable to mutationally activated Concertina or the IRES vector
expressing GFP only (Fig. 7B). GFP levels in cell lysates were
similar, suggesting that the bicistronic mRNAs encoding all six
chimeras were comparable in levels and translation rate (Fig.
7B). These results indicated the switch regions and C-terminal
domain of Ga12 harbor determinants that are independently
required for SRE activation in HEK293 cells because re-
placement of either domain with Concertina sequence abro-
gated this response. To define determinants within the Ga12
C terminus critical for this signaling function, we aligned the
Ga12 and Concertina C-terminal domains and found two
regions of close homology, separated by a divergent region
spanning Lys304 to Phe345 in Ga12 and Cys379 to Tyr423 in
Concertina (Fig. 7A). To determine whether this region harbors
Ga12-specific determinants of SRE activation, we engineered
a “sub-chimera” (designated chimera 4-sub) in which this Ga12
region in chimera 4 was replaced by Concertina sequence.
Because N-terminal epitope-tagging of Concertina did not
disrupt its ability to stimulate S2 cell contraction (Fig. 6, B and
C), we engineered an N-terminal myc tag in chimeras 4 and
4-sub and similarly tagged the other chimeras that harbored
the Concertina N-terminal domain (chimeras 3 and 5). As
shown in Fig. 7C, chimera 4-sub displayed near-complete loss
of SRE signaling, even though immunoblots showed similar
expression levels to chimera 4. Myc-tagged chimeras 3, 4, and
5 generated essentially the same SRE-luciferase readouts as
their untagged forms (data not shown). We also generated
a variant of myc-Ga12
QL, designated D45, harboring a sub-
stitution that introduced the same C-terminal 45-residue
Concertina sequence found in chimera 4-sub, and as predicted,
this mutation caused a complete loss of SRE activation (Fig.
7C). The corresponding D45 mutant of Ga13
QL, in which its
region spanning Gln301 to Tyr343 was replaced by the
Fig. 5. Differential effects of Hsp90 inhibition and SRE-uncoupling
mutations in Ga12 and Ga13. (A) Effects of geldanamycin (left graph)
and Hsp90-specific siRNA (right graph) on Ga12- and Ga13-mediated SRE
activation are shown. HEK293 cells grown in 12-well plates were
transfected with 0.2 mg of SRE-luciferase and 0.02 mg of pRL-TK, plus
1 mg of a constitutively active variant of either Ga12 (12) or Ga13 (13). For
the left graph, cells were serum-starved for 24 hours, and then 1 mg/ml
geldanamycin (geld) was added for 6 hours. For the right graph, siRNA
specific to cytoplasmic Hsp90-awas cotransfected with the above plasmids
as described inMaterials and Methods. Luminometry assays were performed
as described in Fig. 2, and each G12/13 control sample (geldanamycin absent,
or siRNA absent) was set at 100%. For siRNA experiments, cell lysates were
subjected to immunoblot analysis, using antibodies specific to Hsp90-a (Santa
Cruz Biotechnology) and actin (clone C4; Millipore), and representative blots
are shown. Results presented in each graph are the mean of three or more
independent experiments, with error bars representing 6 S.E.M. Effects of
geldanamycin (left graph) and siRNA (right graph) were analyzed by one-way
analysis of variance for significant difference in disruption of the Ga12
response compared with disruption of the Ga13 response (**P , 0.001). (B)
HEK293 cells were transfected with SRE-luciferase and pRL-TK as described
above plus 1 mg of each Ga plasmid. All constructs encoded the constitutively
active form of the Ga protein (12 or 13), and substitutions of class-distinctive
residues are indicated below the x-axis (e.g., F to I). Additional mutants were
tested: QE/QK, Q232E/Q234K substitutions in constitutively active Ga12;
EQ/KQ, E229Q/K231Q substitutions in constitutively active Ga13. Data are
presented as mean 6 range and are the result of three or more independent
experiments per construct. (C) Rendering of Ga12 (PDB ID 1ZCA; Kreutz
et al., 2006) is shown in blue cartoon and Ga13 (PDB ID 3AB3; Hajicek et al.,
2011) in light pink cartoon with the bound nucleotide displayed as sticks and
colored by atom type with carbons in white. For Ga13, side chains of Leu198,
Glu229, Lys231, and Phe234 are displayed as magenta sticks and numbered.
Corresponding Ga12 side chains of Leu201, Gln232, Gln234, and Phe237 are
shown as green sticks and are not numbered in this diagram. Figure was
rendered in The PyMOL Molecular Graphics System, Version 1.5.0.1
Schrödinger, LLC.
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aforementioned Concertina sequence, exhibited robust SRE
stimulation (Fig. 7C). These findings bolster our results shown
in Fig. 5, suggesting that Ga12 and Ga13 use different
structural features and effector binding events in stimulating
this cell proliferative pathway. Taken as a whole, our results
define specific residues in the switch regions, as well as
a region near the C terminus, that differ between Ga12 and its
Drosophila homolog and are required for SRE signaling by
Ga12, but not Ga13.
Discussion
To illuminate the structural features of Ga12 and Ga13 that
mediate their signaling functions, a useful approach has been
to test mutants for disruption of cellular responses or binding
to downstream targets (Jones and Gutkind, 1998; Adarichev
et al., 2003; Nakamura et al., 2004; Vazquez-Prado et al.,
2004; Grabocka and Wedegaertner, 2005). Such studies have
revealed Ga12 determinants of binding to effectors that include
RhoGEFs, protein phosphatase-2A, and polycystin-1 (Meigs
et al., 2005; Zhu et al., 2007; Yu et al., 2011). Our current study
was guided by a method that identified “class-distinctive”
residues within each Ga protein and deduced the ancestral,
“nonclass-distinctive” residue at each position (Temple et al.,
2010). We engineered a panel of Ga12 mutants by converting
each class-distinctive residue to its nonclass-distinctive coun-
terpart; these substitutions were intended to render features of
Ga12 as ancestral-like conformations that might lack ability to
engage specific targets. These mutants revealed Ga12 residues
required for binding to Hsp90 but not RhoGEFs: Leu201 just
upstream of the switch I region and Phe237 and Gln232/
Gln234 within the switch II region. Unexpectedly, these
mutations matched the subset of class-distinctive substitutions
we identified as disruptive to Ga12 stimulation of SRE-
mediated transcription. The effects of geldanamycin, which
inhibits ATP binding to the Hsp90 homodimer and would be
predicted to disrupt its functional interaction with client
proteins that include Ga12, suggest a relationship between
Ga12-Hsp90 interaction and SRE activation, and this hypoth-
esis is further supported by our results after siRNA-mediated
targeting of Hsp90 expression (Fig. 5). However, the incomplete
effect of geldanamycin on Ga12-stimulated SRE signaling
leaves open the possibility that the aforementioned class-
distinctive mutations disrupt SRE signaling by hindering Ga12
Fig. 6. Differential effects of Ga12 and Concertina on SRE-mediated transcription and cytoskeletal rearrangements. (A) Effect of Concertina variants on
SRE-mediated transcriptional activation. HEK293 cells were transfected with a GFP-encoding IRES vector harboring myc-Ga12
QL (12QL), no additional
coding sequence (none), or Concertina variants with the following designations: wt, wild-type; RC, R277C; QL, Q303L; TF, T311F. For each sample,
luciferase assays were performed (graph) and GFP levels were determined by immunoblot analysis (inset) to allow indirect measure of expression of
Concertina variants. Data shown are a representative of three independent experiments. (B) Effect of Concertina and its Q306E/Q308K variant on cell
contraction. S2 cells expressing inducible myc-tagged, constitutively active Concertina (CtaQL) or the same protein harboring Q306E/Q308K
substitutions (QE/QK) were induced with 50 mM copper sulfate and 24 hours later scored for contractility as described inMaterials and Methods. Cells
were stained with phalloidin (top row) and anti-myc antibody (middle row), and images were merged (bottom row). Scale bar is 10 mm, and images are
from a representative of three independent experiments. (C) Compiled quantitative data from experiments described in (B) are shown, with bars
indicating S.E.M. (D) HEK293 cells were assayed for basal RhoA activity 36–42 hours after transfection with constitutively active (12QL) or inactive
(12GA) myc-tagged Ga12, or the indicated mutants of myc-Ga12
QL. Blots were developed with SuperSignal West Pico chemiluminescent substrate
(Pierce, Rockford, IL) and Kodak Biomax film, and representative blots of active RhoA (Rho-GTP) precipitated by GST-RBD versus total RhoA in cell
lysates are shown, along with blots of Ga12 and actin in the same experiment. RhoA activity is the ratio of active RhoA to total RhoA signal, with
densitometry (NIH ImageJ software) used to quantify results from seven independent experiments. Results are graphed as the -fold increase over cells
expressing inactive, GDP-bound Ga12 (12GA). Graphical data representmean6 S.E.M.; **P, 0.001 as calculated through analysis of variance using the
Kruskal–Wallis test.
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interaction with other, unexamined binding partners in addition
to Hsp90.
Ga12 signaling to SRE requires activation of Rho (Fromm
et al., 1997). Because the SRE-uncoupled Ga12 mutants
exhibited normal binding to RhoGEFs, as well as robust
Rho activation for mutants L201R and F237I, these class-
distinctive Ga12 residues may mediate engagement of an
effector pathway(s) required in addition to the canonical
RhoGEF-Rho pathway for SRE activation. Results for the
Q232E/Q234K mutant of Ga12 were less clear; these sub-
stitutions disrupted SRE activation and also diminished Rho
activation, even though RhoGEF binding remained intact. It
is possible this mutation disrupts SRE signaling by partially
uncoupling Ga12 from the RhoGEF-Rho signaling pathway.
However, our finding that Concertina harboring the same
mutation triggered normal Rho-mediated contractility in S2
cells (Fig. 6) suggests that this conserved Gln/Gln pair is not
required for the ancient G12/13-RhoGEF-Rho axis that
mediates cell shape changes in organisms such as Drosophila
and C. elegans (Barrett et al., 1997; Yau et al., 2003). Our
overall results suggest the L201R and F237I mutants are
more decisive than the Q232E/Q234K mutant in selectively
uncoupling Ga12 from Hsp90 without perturbing Ga12-
RhoGEF interaction. It is possible this Gln/Gln pair plays
a Ga12-specific role in mediating Ga binding to a target
protein (e.g., Hsp90) that must be engaged for RhoGEF-Rho
signaling to commence. The Drosophila Ga12 homolog Concer-
tina may lack this requirement, as its Q306E/Q308K mutant
was unimpeded in triggering cytoskeletal rearrangements.
Taken as a whole, our results suggest the class-distinctive
residues essential for Ga12-specific SRE activation either
mediate a Rho-independent signaling pathway or participate
in an effector binding event that facilitates coupling of Ga12 to
the RhoGEF-Rho pathway.
Both Ga12 and Ga13 stimulate SRE-mediated transcription
via mechanisms that are sensitive to Rho inhibition (Fromm
et al., 1997; Bhattacharyya and Wedegaertner, 2000; Shi
et al., 2000). However, Hsp90 perturbation preferentially
hindered SRE activation by Ga12 in comparison with Ga13
(Fig. 5), suggesting that nonredundant signaling mechanisms
evolved within the G12/13 class. Geldanamycin inhibits
thrombin-mediated signaling through protease-activated re-
ceptor 1 in mouse neuroblasts but fails to inhibit LPA-
mediated signaling (Pai and Cunningham, 2002), and because
the thrombin receptor preferentially couples to Ga12 whereas
LPA signaling uses Ga13 (Yamaguchi et al., 2003), this finding
implicates Hsp90 in a Ga12-specific role. Furthermore, our
mutations of residues Leu201 and Phe237 disrupted Ga12 but
Fig. 7. Identification of additional determinants of SRE
activation in Ga12. (A) Schematic of Ga12/Concertina
chimeras is shown. Chimeras were engineered as de-
scribed in Materials and Methods, with the switch regions
demarcated by the N-terminal boundary of the switch I
region (Cys276 of Concertina, Ala202 of Ga12) and the
C-terminal boundary of the switch III region (Arg342 of
Concertina, Arg267 of Ga12). An activating Gln-to-Leu
mutation was engineered in the switch II region of each
construct. For chimera 4-sub, the indicated 45-residue
Concertina region was introduced to chimera 4 in place of
the indicated 42-residue Ga12 region. (B) Stimulation of
SRE-mediated transcription in HEK293 cells (see Materi-
als and Methods) by Ga12/Concertina chimeras 1–6 is
shown. SRE activation is displayed as percent of the
positive control myc-Ga12
QL (12QL) in the same experi-
ment. Values are mean 6 range for three or more
independent trials per chimera, with only the mean
displayed for samples with values #3% of positive control.
Immunoblot levels of GFP, coexpressed in the IRES vector
harboring each chimera, are shown (lower panel). (C)
Effects of C-terminal Concertina substitutions within
chimera 4 and G12/13 proteins are shown. N-terminally
myc-tagged chimera 4 and chimera 4-sub were tested for
SRE activation, and mean 6 range is shown for three
independent experiments. Lysates were examined by
immunoblot (IB) analysis using anti-myc antibody; results
from a representative experiment are shown. SRE activa-
tion assays for mutants harboring the aforementioned 45-
residue Concertina region at the C terminus of myc-Ga12
QL
(12QL-D45) and Ga13
QL (13QL-D45) are presented
in comparison with positive controls myc-Ga12
QL and
Ga13
QL, respectively, and results are shown as mean 6
range for three independent experiments. Comparative
expression levels of the two Ga12 constructs, and the two
Ga13 constructs, were determined by immunoblot analysis
using anti-Ga12 (Santa Cruz Biotechnology) and anti-Ga13
(EMD Millipore) antibodies, and images from a represen-
tative experiment are shown.
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not Ga13 in stimulating SRE-mediated transcription, despite
conservation of these amino acids in both proteins. Another
apparent Ga12 determinant of SRE activation, the Gln232/
Gln234 pair, is conserved throughout taxa harboring the G12/
13 class, whereas the Gs, Gi, and Gq classes use Glu/Lys
at these positions. Therefore, it is intriguing that Ga13
“reverted” to the ancestral Glu/Lys pair during its evolution
and that the Gln/Gln pair is critical for Ga12 in SRE
activation, whereas Ga13 utilizes a signaling mechanism
unaffected by Glu/Lys mutation to Gln/Gln. The functional
significance of this Glu/Lys motif in Ga13 remains to be
determined. Substitution of this Glu residue in Ga13 (Glu229)
for a positively charged residue disrupted its RhoGEF
binding, SRE activation, and recruitment of p115RhoGEF to
the plasmamembrane. Conversely, mutation of Glu229 to Ala
did not disrupt RhoGEF binding by Ga13, and effects on SRE
signaling were not reported (Grabocka and Wedegaertner,
2005). Disruption of SRE signaling by charge reversal at this
site may be due solely to interference with RhoGEF engage-
ment, whereas E229Q substitution in our study allowed Ga13
to retain SRE activation and presumably functional RhoGEF
binding.
Because Ga12 and Ga13 both stimulate SRE-mediated
transcription, albeit through nonredundant mechanisms,
the inability of the closely related Concertina to activate this
pathway in HEK293 cells was surprising. It is possible that
requisite downstream effector proteins in mammalian cells
are not engaged by Concertina or that this fly protein fails to
fold properly in these cells. However, our data from Ga12/
Concertina chimeras (Fig. 7) demonstrate that the N-terminal
275 amino acids, as well as a 45-residue C-terminal region of
Concertina, can fold correctly and facilitate robust Ga12- or
Ga13-mediated signaling in HEK293 cells. These results
suggest that key growth-signaling properties, including
mechanisms potentially involved in oncogenic transforma-
tion, evolved in the lineage that yielded mammalian G12/13
proteins after divergence from Concertina. Moreover, because
Concertina activates cytoskeletal rearrangements in Dro-
sophila through a RhoGEF (DRhoGEF2) homologous to the
G12/13-coupled mammalian RhoGEFs (Barrett et al., 1997),
the striking difference in Ga12 and Concertina signaling to
SRE in HEK293 cells bolsters the hypothesis that Ga12
stimulation of this response requires additional effector(s) in
these cells besides the canonical RhoGEF-Rho axis. These
findings compelled us to interchange residues between Ga12
and Concertina, revealing F237T mutation in Ga12 as
disruptive to SRE activation in HEK293 cells, whereas
replacement of the Ga12 residue Leu201 with the Concertina
residue His had no apparent effect. These results suggest
Concertina harbors some, not all, of the structural features
necessary for SRE activation in mammalian cells and that
such characteristics were partially in place in a common
ancestor of Concertina and the mammalian G12/13 proteins.
Furthermore, Concertina provided a uniquely useful “foil” for
Ga12 in our study, due to its ∼55% identical amino acid
sequence and shared signaling properties in regulating Rho-
mediated cytoskeletal rearrangements. Our experiments
utilizing Ga12/Concertina chimeras revealed both the domain
encompassing the switch regions and a span near the Ga12
C terminus as harboring independent determinants of SRE
activation. Furthermore, our studies using a corresponding
Ga13/Concertina chimera suggested that the same C-terminal
span in Ga13 is not involved in its signaling toward SRE
activation. Future comparison of G12/13 proteins with these
and other chimeras, in assays of effector binding and cellular
signaling readouts, may reveal structural features and mech-
anisms used by Ga12 and Ga13 to activate proliferation,
migration, and other responses.
A question that arises from our findings is: what advantage
was gained by Ga12 and Ga13 evolving different mechanisms
for stimulating SRE-mediated transcription? In considering
this question, it is noteworthy that similar examples have
been reported in the G12/13 class. Both Ga12 and Ga13
stimulate Na1/H1 exchange across the plasma membrane;
however, Ga12 requires protein kinase C, whereas Ga13 uses
a pathway independent of this kinase (Dhanasekaran et al.,
1994). Ga13 stimulates activity of the Na
1/H1 exchangers
NHE-1, NHE-2, and NHE-3, but Ga12 stimulates only the
latter two proteins while inhibiting NHE-1 (Lin et al., 1996).
Also, Ga12-mediated regulation of tight junctions and para-
cellular permeability occurs via a Src-dependent mechanism,
whereas the Ga13-mediated response does not require Src
(Meyer et al., 2003; Donato et al., 2009). In another example,
recruitment of p115RhoGEF to the inner face of the plasma
membrane by activated Ga13 is dependent on RhoA, whereas
recruitment by activated Ga12 is refractory to RhoA inhibition
(Bhattacharyya et al., 2009). One clue regarding different
Hsp90 requirements of the G12/13 proteins has emerged from
studies of lipid rafts; Ga12, but not Ga13, localizes to these
sphingolipid- and cholesterol-enriched areas, and targeting of
Ga12 to lipid rafts is sensitive to Hsp90 inhibition (Waheed
and Jones, 2002). The different subcellular locations of Ga12
and Ga13 may facilitate differences in signaling inputs,
downstream effectors, and regulators of their respective
signaling properties, so that a binding partner such as
Hsp90 may be critical for one G12/13 protein but not the
other in driving a common downstream response such as SRE
activation.
In addition to illuminating target sites for inhibiting Ga12-
mediated signaling to SRE-regulated genes, our findings
validate the “class-distinctive” methodology (Temple et al.,
2010) as a technique that could be extended to other Ga
classes to dissect the roles of different binding partners. With
the increasing list of proteins that interact with Ga12, Ga13, or
other Ga proteins, class-distinctive mutants should be useful
for identifying connections between specific Ga-effector inter-
actions and cellular responses mediated by different classes of
G proteins.
Acknowledgments
The authors thank Tohru Kozasa, Tatyana Voyno-Yasenetskaya,
Channing Der, and Christopher Mack for providing reagents, and
Dan Kaplan, Pat Casey, and Aisha Chow for helpful discussions.
Authorship Contributions
Participated in research design: Montgomery, Temple, Peters,
Tolbert, Rogers, Jones, Meigs.
Conducted experiments: Montgomery, Peters, Tolbert, Smolski,
Hamilton, Tagliatela, Rogers, Meigs.
Contributed new reagents or analytic tools: Montgomery, Peters,
Booker, Martin, Hamilton, Tagliatela, Rogers, Meigs.
Performed data analysis: Montgomery, Temple, Peters, Tolbert,
Rogers, Jones, Meigs.
Wrote or contributed to the writing of the manuscript: Montgomery,
Temple, Peters, Tolbert, Rogers, Jones, Meigs.
596 Montgomery et al.
References
Adarichev VA, Vaiskunaite R, Niu J, Balyasnikova IV, and Voyno-Yasenetskaya TA
(2003) Ga13-mediated transformation and apoptosis are permissively dependent
on basal ERK activity. Am J Physiol Cell Physiol 285:C922–C934.
Barrett K, Leptin M, and Settleman J (1997) The Rho GTPase and a putative Rho-
GEF mediate a signaling pathway for the cell shape changes in Drosophila gas-
trulation. Cell 91:905–915.
Bhattacharyya R, Banerjee J, Khalili K, and Wedegaertner PB (2009) Differences in
Galpha12- and Galpha13-mediated plasma membrane recruitment of p115-Rho-
GEF. Cell Signal 21:996–1006.
Bhattacharyya R and Wedegaertner PB (2000) Galpha 13 requires palmitoylation for
plasma membrane localization, Rho-dependent signaling, and promotion of p115-
RhoGEF membrane binding. J Biol Chem 275:14992–14999.
Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni
MR, and Hamm HE (2003) Insights into G protein structure, function, and regu-
lation. Endocr Rev 24:765–781.
Chan AM, Fleming TP, McGovern ES, Chedid M, Miki T, and Aaronson SA (1993)
Expression cDNA cloning of a transforming gene encoding the wild-type Ga12 gene
product. Mol Cell Biol 13:762–768.
Dhanasekaran N, Prasad MV, Wadsworth SJ, Dermott JM, and van Rossum G (1994)
Protein kinase C-dependent and -independent activation of Na1/H1 exchanger by
Ga12 class of G proteins. J Biol Chem 269:11802–11806.
Donato R, Wood SA, Saunders I, Gundsambuu B, Yan Mak K, Abbott CA, and Powell
BC (2009) Regulation of epithelial apical junctions and barrier function by Gal-
pha13. Biochim Biophys Acta 1793:1228–1235.
Evelyn CR, Wade SM, Wang Q, Wu M, Iñiguez-Lluhí JA, Merajver SD, and Neubig
RR (2007) CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Mol Cancer Ther 6:2249–2260.
Friedman EJ, Temple BRS, Hicks SN, Sondek J, Jones CD, and Jones AM (2009)
Prediction of protein-protein interfaces on G-protein b subunits reveals a novel
phospholipase C b2 binding domain. J Mol Biol 392:1044–1054.
Fromm C, Coso OA, Montaner S, Xu N, and Gutkind JS (1997) The small GTP-
binding protein Rho links G protein-coupled receptors and Galpha12 to the serum
response element and to cellular transformation. Proc Natl Acad Sci USA 94:
10098–10103.
Goulimari P, Knieling H, Engel U, and Grosse R (2008) LARG and mDia1 link
Galpha12/13 to cell polarity and microtubule dynamics. Mol Biol Cell 19:30–40.
Grabocka E and Wedegaertner PB (2005) Functional consequences of Ga13 muta-
tions that disrupt interaction with p115RhoGEF. Oncogene 24:2155–2165.
Gu JL, Müller S, Mancino V, Offermanns S, and Simon MI (2002) Interaction of
Ga(12) with G a(13) and G a(q) signaling pathways. Proc Natl Acad Sci USA 99:
9352–9357.
Guilluy C, Swaminathan V, Garcia-Mata R, O’Brien ET, Superfine R, and Burridge K
(2011) The Rho GEFs LARG and GEF-H1 regulate the mechanical response to
force on integrins. Nat Cell Biol 13:722–727.
Hajicek N, Kukimoto-Niino M, Mishima-Tsumagari C, Chow CR, ShirouzuM, Terada T,
Patel M, Yokoyama S, and Kozasa T (2011) Identification of critical residues in G(a)13
for stimulation of p115RhoGEF activity and the structure of the G(a)13-p115RhoGEF
regulator of G protein signaling homology (RH) domain complex. J Biol Chem 286:
20625–20636.
Hill CS, Wynne J, and Treisman R (1995) The Rho family GTPases RhoA, Rac1, and
CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159–1170.
Hinson JS, Medlin MD, Lockman K, Taylor JM, and Mack CP (2007) Smooth muscle
cell-specific transcription is regulated by nuclear localization of the myocardin-
related transcription factors. Am J Physiol Heart Circ Physiol 292:H1170–H1180.
Jiang H, Wu D, and Simon MI (1993) The transforming activity of activated Ga12.
FEBS Lett 330:319–322.
Jones TL and Gutkind JS (1998) Galpha12 requires acylation for its transforming
activity. Biochemistry 37:3196–3202.
Juneja J and Casey PJ (2009) Role of G12 proteins in oncogenesis and metastasis. Br
J Pharmacol 158:32–40.
Kelly P, Casey PJ, and Meigs TE (2007) Biologic functions of the G12 subfamily of
heterotrimeric G proteins: growth, migration, and metastasis. Biochemistry 46:
6677–6687.
Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, Daaka Y, Dewhirst MW, Fields
TA, and Casey PJ (2006a) The G12 family of heterotrimeric G proteins promotes
breast cancer invasion and metastasis. Proc Natl Acad Sci USA 103:8173–8178.
Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y, and Casey PJ (2006b) A role
for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J Biol
Chem 281:26483–26490.
Kozasa T and Gilman AG (1995) Purification of recombinant G proteins from Sf9 cells
by hexahistidine tagging of associated subunits: characterization of a 12 and in-
hibition of adenylyl cyclase by a z. J Biol Chem 270:1734–1741.
Kreutz B, Yau DM, Nance MR, Tanabe S, Tesmer JJG, and Kozasa T (2006) A new
approach to producing functional G a subunits yields the activated and deactivated
structures of Ga(12/13) proteins. Biochemistry 45:167–174.
Lin X, Voyno-Yasenetskaya TA, Hooley R, Lin CY, Orlowski J, and Barber DL (1996)
Galpha12 differentially regulates Na1-H1 exchanger isoforms. J Biol Chem 271:
22604–22610.
Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, and Treisman R (2009)
Myocardin-related transcription factors and SRF are required for cytoskeletal
dynamics and experimental metastasis. Nat Cell Biol 11:257–268.
Medlin MD, Staus DP, Dubash AD, Taylor JM, and Mack CP (2010) Sphingosine
1-phosphate receptor 2 signals though leukemia-associated RhoGEF (LARG), to
promote smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 30:
1779–1786.
Meigs TE, Juneja J, DeMarco CT, Stemmle LN, Kaplan DD, and Casey PJ (2005)
Selective uncoupling of Ga12 from Rho-mediated signaling. J Biol Chem 280:
18049–18055.
Meyer TN, Hunt J, Schwesinger C, and Denker BM (2003) Galpha12 regulates epi-
thelial cell junctions through Src tyrosine kinases. Am J Physiol Cell Physiol 285:
C1281–C1293.
Miller RT, Masters SB, Sullivan KA, Beiderman B, and Bourne HR (1988) A muta-
tion that prevents GTP-dependent activation of the a chain of Gs. Nature 334:
712–715.
Nakamura S, Kreutz B, Tanabe S, Suzuki N, and Kozasa T (2004) Critical role of
lysine 204 in switch I region of Galpha13 for regulation of p115RhoGEF and
leukemia-associated RhoGEF. Mol Pharmacol 66:1029–1034.
Offermanns S, Mancino V, Revel JP, and Simon MI (1997) Vascular system defects
and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275:
533–536.
OldhamWM and HammHE (2008) Heterotrimeric G protein activation by G-protein-
coupled receptors. Nat Rev Mol Cell Biol 9:60–71.
Pai KS and Cunningham DD (2002) Geldanamycin specifically modulates thrombin-
mediated morphological changes in mouse neuroblasts. J Neurochem 80:715–718.
Parks S and Wieschaus E (1991) The Drosophila gastrulation gene concertina enc-
odes a Ga-like protein. Cell 64:447–458.
Peterson LB and Blagg BS (2009) To fold or not to fold: modulation and consequences
of Hsp90 inhibition. Future Med Chem 1:267–283.
Ren XD, Kiosses WB, and Schwartz MA (1999) Regulation of the small GTP-binding
protein Rho by cell adhesion and the cytoskeleton. EMBO J 18:578–585.
Rogers SL and Rogers GC (2008) Culture of Drosophila S2 cells and their use for
RNAi-mediated loss-of-function studies and immunofluorescence microscopy. Nat
Protoc 3:606–611.
Samant RS, Clarke PA, and Workman P (2012) The expanding proteome of the
molecular chaperone HSP90. Cell Cycle 11:1301–1308.
Shi CS, Sinnarajah S, Cho H, Kozasa T, and Kehrl JH (2000) G13a-mediated PYK2
activation. PYK2 is a mediator of G13a-induced serum response element-dependent
transcription. J Biol Chem 275:24470–24476.
Sternweis PC, Carter AM, Chen Z, Danesh SM, Hsiung YF, and Singer WD (2007)
Regulation of Rho guanine nucleotide exchange factors by G proteins. Adv Protein
Chem 74:189–228.
Suzuki N, Hajicek N, and Kozasa T (2009) Regulation and physiological functions of
G12/13-mediated signaling pathways. Neurosignals 17:55–70.
Temple BRS, Jones CD, and Jones AM (2010) Evolution of a signaling nexus con-
strained by protein interfaces and conformational states. PLOS Comput Biol 6:
e1000962.
Uetrecht AC and Bear JE (2009) Golgi polarity does not correlate with speed or
persistence of freely migrating fibroblasts. Eur J Cell Biol 88:711–717.
Vaiskunaite R, Kozasa T, and Voyno-Yasenetskaya TA (2001) Interaction between
the Ga subunit of heterotrimeric G(12) protein and Hsp90 is required for Ga(12)
signaling. J Biol Chem 276:46088–46093.
Vara Prasad MV, Shore SK, and Dhanasekaran N (1994) Activated mutant of
G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene 9:
2425–2429.
Vázquez-Prado J, Miyazaki H, Castellone MD, Teramoto H, and Gutkind JS (2004)
Chimeric G a i2/G a 13 proteins reveal the structural requirements for the binding
and activation of the RGS-like (RGL)-containing Rho guanine nucleotide exchange
factors (GEFs) by G a 13. J Biol Chem 279:54283–54290.
Waheed AA and Jones TLZ (2002) Hsp90 interactions and acylation target the
G protein Galpha 12 but not Galpha 13 to lipid rafts. J Biol Chem 277:32409–32412.
Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G, Richardson JA,
Nordheim A, and Olson EN (2002). Potentiation of serum response factor activity
by a family of myocardin-related transcription factors. Proc Natl Acad Sci USA 99:
14855–14860.
Worzfeld T, Wettschureck N, and Offermanns S (2008) G(12)/G(13)-mediated sig-
nalling in mammalian physiology and disease. Trends Pharmacol Sci 29:582–589.
Xu N, Voyno-Yasenetskaya T, and Gutkind JS (1994) Potent transforming activity of
the G13 a subunit defines a novel family of oncogenes. Biochem Biophys Res
Commun 201:603–609.
Yamaguchi Y, Katoh H, and Negishi M (2003) N-terminal short sequences of a
subunits of the G12 family determine selective coupling to receptors. J Biol Chem
278:14936–14939.
Yau DM, Yokoyama N, Goshima Y, Siddiqui ZK, Siddiqui SS, and Kozasa T (2003)
Identification and molecular characterization of the Ga12-Rho guanine nucleotide
exchange factor pathway in Caenorhabditis elegans. Proc Natl Acad Sci USA 100:
14748–14753.
Yu W, Ritchie BJ, Su X, Zhou J, Meigs TE, and Denker BM (2011) Identification of
polycystin-1 and Ga12 binding regions necessary for regulation of apoptosis. Cell
Signal 23:213–221.
Zhu D, Tate RI, Ruediger R, Meigs TE, and Denker BM (2007) Domains necessary for
Galpha12 binding and stimulation of protein phosphatase-2A (PP2A): Is Galpha12
a novel regulatory subunit of PP2A? Mol Pharmacol 71:1268–1276.
Address correspondence to: Thomas E. Meigs, Department of Biology,
University of North Carolina at Asheville, CPO 2040, One University Heights,
Asheville, NC 28804. E-mail: tmeigs@unca.edu
Ga12 Determinants of SRE Activation 597
